B. Hubby

发表

Phylogenetic Distribution of CRISPR-Cas Systems in Antibiotic-Resistant Pseudomonas aeruginosa

Jean-Baptiste Veyrieras, Alex van Belkum, Daniel Brami, 2015, mBio.

Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization

Andrew N. Gray, B. Hubby, Y. Koh, 2009, The Prostate.

Cationic HDL mimetics enhance in vivo delivery of self-replicating mRNA.

Wei He, A. Evans, N. Fischer, 2020, Nanomedicine : nanotechnology, biology, and medicine.

Construction and use of a multi-competitor gene for quantitative RT-PCR using existing primer sets.

R. McGraw, R. Tarleton, B. Hubby, 1995, Journal of immunological methods.

Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects

D. Niedzwiecki, G. Devi, M. Morse, 2012, Cancer Immunology, Immunotherapy.

Restricted and selective tropism of a Venezuelan equine encephalitis virus-derived replicon vector for human dendritic cells.

Kehui Wang, E. Nelson, B. Hubby, 2007, Viral immunology.

Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages.

Andrew N. Gray, B. Hubby, W. M. Kast, 2009, Vaccine.

Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection.

D. Suarez, B. Hubby, M. Sylte, 2007, Vaccine.

An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer.

D. Niedzwiecki, H. Lyerly, G. Devi, 2010, The Journal of clinical investigation.

Cell-free production of a functional oligomeric form of a Chlamydia major outer-membrane protein (MOMP) for vaccine development

K. Lam, L. Xing, A. Noy, 2017, The Journal of Biological Chemistry.

Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity.

Andrew N. Gray, B. Hubby, M. L. García-Hernández, 2008, Cancer research.

Analysis of Venezuelan Equine Encephalitis Replicon Particles Packaged in Different Coats

B. Hubby, J. Rayner, K. Kamrud, 2008, PloS one.

Development and preclinical evaluation of an alphavirus replicon vaccine for influenza.

Jordan A. Wagner, Maureen F. Maughan, J. Chulay, 2007, Vaccine.

In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer.

Andrew N. Gray, B. Hubby, M. L. García-Hernández, 2007, Cancer research.

VRP immunotherapy targeting neu: treatment efficacy and evidence for immunoediting in a stringent rat mammary tumor model

Kehui Wang, E. Nelson, B. W. Sur, 2007, Breast Cancer Research and Treatment.

Development of a nanoparticle-based influenza vaccine using the PRINT technology.

J. DeSimone, B. Hubby, F. Malinoski, 2013, Nanomedicine : nanotechnology, biology, and medicine.

Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice

D. G. Gibson, J. Gill, Z. Qi, 2013, Emerging Microbes & Infections.

Rendering protein-based particles transiently insoluble for therapeutic applications.

Ashish A. Pandya, G. Owens, J. DeSimone, 2012, Journal of the American Chemical Society.

Digital-to-biological converter for on-demand production of biologics

J Craig Venter, D. G. Gibson, Martina Felderman, 2017, Nature Biotechnology.

Phage Therapy in the Era of Synthetic Biology.

K. Cady, E. Barbu, B. Hubby, 2016, Cold Spring Harbor perspectives in biology.

An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer.

D. Niedzwiecki, G. Devi, H. Lyerly, 2010, The Journal of clinical investigation.